These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 925608)

  • 21. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in normal mice.
    Wolmark N; Levine M; Fisher B
    J Reticuloendothel Soc; 1974 Oct; 16(4):252-7. PubMed ID: 4455907
    [No Abstract]   [Full Text] [Related]  

  • 22. Monoclonal antibodies directed against mouse macrophages in different stages of activation for tumor cytotoxicity.
    Taniyama T; Tokunaga T
    J Immunol; 1983 Aug; 131(2):1032-7. PubMed ID: 6863926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of Propionibacterium acnes-activated macrophages on the tumor metastasis enhanced by tumor-specific immunosuppression.
    Tsuchida T; Fujiwara H; Tsuji Y; Hamaoka T
    Gan; 1981 Apr; 72(2):205-12. PubMed ID: 7286546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modifications in the handling in vitro of 125I-labelled keyhole limpet haemocyanin by peritoneal macrophages from mice pretreated with the adjuvant Corynebacterium parvum.
    Wiener E; Bandieri A
    Immunology; 1975 Aug; 29(2):265-74. PubMed ID: 1158386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
    Miyata H; Himeno K; Nomoto K
    Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
    Gabizon A; Leibovich SJ; Goldman R
    J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common cell-surface antigen associated with murine and feline C-type RNA leukemia viruses.
    Yoshiki T; Mellors RC; Hardy WD
    Proc Natl Acad Sci U S A; 1973 Jun; 70(6):1878-82. PubMed ID: 4352660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paradoxical effects of immunopotentiators on tumors and tumor viruses.
    Morahan PS; Schuller GB; Snodgrass MJ; Kaplan AM
    J Infect Dis; 1976 Jun; 133 Suppl():A249-55. PubMed ID: 932503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the gamma-interferon-mediated induction of antigen-presenting ability in P388D1 cells.
    Zlotnik A; Shimonkevitz RP; Gefter ML; Kappler J; Marrack P
    J Immunol; 1983 Dec; 131(6):2814-20. PubMed ID: 6196401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of resistance to ectromelia virus infection by corynebacterium parvum in murine peritoneal macrophages.
    Cohen DA; Bubel HC
    J Reticuloendothel Soc; 1983 Jan; 33(1):35-46. PubMed ID: 6300395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved cell surface radioiodination of macrophages.
    Kulczycki A; Krause V; Killion CC; Atkinson JP
    J Immunol Methods; 1980; 37(2):133-8. PubMed ID: 7003011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible mechanisms in the anti-tumour activity of C. parvum.
    Cullen RT
    Dev Biol Stand; 1977 Apr 13-15; 38():265-71. PubMed ID: 305375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice.
    Kiya K; Toge T; Harada K; Uozumi T; Hattori T
    Gan; 1981 Jun; 72(3):446-50. PubMed ID: 7319201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells.
    Chen MF; Suzuki H; Yano S
    Anticancer Res; 1992; 12(2):451-6. PubMed ID: 1580562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells.
    Krahenbuhl JL; Lambert LH; Remington JS
    Immunology; 1976 Dec; 31(6):837-46. PubMed ID: 992714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antitumor efficacy of activated macrophages against murine glioma cells].
    Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Ushio Y; Hayakawa T; Tsuda N; Mogami H
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2082-8. PubMed ID: 3717955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a macrophage-specific cell surface antigen.
    Stinnett JD; Kaplan AM; Morahan PS
    J Immunol; 1976 Feb; 116(2):273-8. PubMed ID: 55433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activation of macrophages by Corynebacterium parvum: effect of anti-complementary agents cobra venom factor and sodium cyanate.
    Ghaffar A
    J Reticuloendothel Soc; 1980 Mar; 27(3):327-35. PubMed ID: 7365736
    [No Abstract]   [Full Text] [Related]  

  • 40. Possible mechanisms underlying the induction of cytotoxic macrophages by Corynebacterium parvum: in vitro induction of cytotoxicity in normal macrophages by immune lymphocytes.
    Cullen RT; Ghaffar A
    J Reticuloendothel Soc; 1978 Oct; 24(4):339-49. PubMed ID: 81874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.